Thieler Law Corp, member of the Investor Attorney Network, is investigating whether certain officers and directors of Fusion Pharm Inc (OTCMKTS: FSPM) violated securities laws in connection with certain financial statements.

The investigation seeks to discover if possible claims on behalf of purchasers of the securities of Fusion Pharm Inc (OTCMKTS: FSPM)  concerning whether a series of statements by Fusion Pharm Inc regarding its business, its prospects and its operations were materially false and misleading at the time they were made.

On September 16, 2016, the SEC revealed fraud charges against Fusion Pharm and its CEO, Scott M. Dittman, for deceiving investors by exaggerating Company revenues for supposed sales of PharmPods by round-tripping money from illegal stock sales by anonymous affiliates.

Based in Denver, Colorado, Fusion Pharm Inc manufactures and sells a line of cultivation containers under the PharmPod brand name in the United States.

If you purchased shares of Fusion Pharm Inc (OTCMKTS: FSPM) on or before September 16, 2016, you should contact Thieler Law Corp at mail@thielerlaw.com or call +1 (619) 377 - 4324.

Thieler Law Corp

2534 State Street - Suite 406,

San Diego, CA 92101

by

email: mail@thielerlaw.com 

or

telephone at +1 (619) 377 - 4324

or

visit our website http://www.thielerlaw.com/ 

or

Facsimile: +1 (619) 785 – 3185